Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs72648409 | chr8:53857307 | T/C | 0.000484 | 171 | 24.7 | 27.2 | 6.1 | KM Plot |
PCPG | rs7265464 | chr20:5988364 | A/G | 0 | 176 | 25.53 | 23.53 | 2.93 | KM Plot |
PCPG | rs72661636 | chr1:36426483 | T/C | 0.000208 | 175 | 25.53 | 24.7 | 10.3 | KM Plot |
PCPG | rs72666980 | chr13:114152274 | C/A | 4.5E-12 | 177 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs72676978 | chr4:110976320 | T/C | 0 | 177 | 26.57 | 18 | 2.93 | KM Plot |
PCPG | rs72683290 | chr8:140984225 | C/A | 0 | 177 | 25.4 | 23.43 | 3.17 | KM Plot |
PCPG | rs72713784 | chr15:43115936 | A/G | 2.3E-14 | 177 | 25.47 | 24.85 | 3.17 | KM Plot |
PCPG | rs72713795 | chr15:43141628 | T/A | 2.65E-14 | 176 | 25.53 | 24.85 | 3.17 | KM Plot |
PCPG | rs72719486 | chr15:43189471 | C/T | 2.58E-14 | 175 | 25.87 | 24.62 | 3.17 | KM Plot |
PCPG | rs72721511 | chr15:43286359 | T/C | 2.58E-14 | 176 | 25.87 | 24.03 | 3.17 | KM Plot |
PCPG | rs72723734 | chr14:74311301 | A/T | 5.67E-6 | 170 | 25.47 | 28.3 | 10.57 | KM Plot |
PCPG | rs72723761 | chr14:74374802 | G/A | 1.16E-5 | 176 | 25.4 | 27.2 | 10.43 | KM Plot |
PCPG | rs72723776 | chr14:74433141 | T/C | 9.42E-6 | 177 | 25.28 | 30.33 | 7.4 | KM Plot |
PCPG | rs72725943 | chr14:74554677 | A/C | 2.24E-5 | 176 | 25.4 | 27.43 | 10.3 | KM Plot |
PCPG | rs72725948 | chr14:74563289 | G/A | 2.24E-5 | 176 | 25.4 | 27.43 | 10.3 | KM Plot |